HUTCHMED (China) (HCM) Dividends payables (2019)
HUTCHMED (China)'s (HCM) quarterly Dividends payables came in at -$14.6 million in Q4 2019.
HUTCHMED (China) (HCM) Dividends payables (2019) Analysis & Trends
HUTCHMED (China) (HCM) has 1 years of Dividends payables data on file, last reported at -$14.6 million in Q4 2019.
- On a quarterly basis, Dividends payables changed N/A year-over-year to -$14.6 million in Q4 2019; TTM through Dec 2019 was -$14.6 million, a N/A change from a year earlier, with the FY2019 full-year figure at -$14.6 million, changed N/A from the prior year.
- Dividends payables for Q4 2019 stood at -$14.6 million.
- Over the last five years, Dividends payables for HCM reached as high as -$14.6 million in Q4 2019 and fell as low as -$14.6 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 224.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -14.62 Mn |